Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Hayward, California
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 609 filings
- On EDGAR
- CIK 1724521
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 35
News 8 of 98
Prospectuses and Registrations 8 of 27
- 424B5 Prospectus supplement for an offering Oct 22, 2026
- 424B5 Prospectus supplement for an offering Oct 21, 2026
- S-3ASR Automatic shelf registration Feb 25, 2026
- S-8 Registration statement for an employee plan Feb 25, 2026
- 424B5 Prospectus supplement for an offering Oct 31, 2025
- 424B5 Prospectus supplement for an offering Oct 30, 2025
- S-8 Registration statement for an employee plan Feb 25, 2025
- 424B5 Prospectus supplement for an offering Feb 18, 2025
Proxies 8 of 18
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Apr 22, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2025
- DEFA14A Extra proxy material Apr 23, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2024
- DEFA14A Extra proxy material Apr 21, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2023
Ownership 8 of 401
- 4 Insider reported a trade Aug 24, 2026
- 144 Notice of a proposed sale of restricted stock Aug 21, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 7, 2026
- 4 Insider reported a trade Jul 13, 2026
- 144 Notice of a proposed sale of restricted stock Jul 9, 2026
- 144 Notice of a proposed sale of restricted stock Jun 24, 2026
- 4 Insider reported a trade Jun 24, 2026
- 144 Notice of a proposed sale of restricted stock Jun 22, 2026
Other 8 of 30
- CT ORDER Sep 28, 2026
- ARS Annual report sent to shareholders Apr 21, 2026
- ARS Annual report sent to shareholders Apr 22, 2025
- ARS Annual report sent to shareholders Apr 24, 2024
- ARS Annual report sent to shareholders Apr 25, 2023
- UPLOAD Comment letter from SEC staff Jun 7, 2022
- CORRESP Reply to SEC staff Jun 3, 2022
- UPLOAD Comment letter from SEC staff May 10, 2022
Everything here comes from Arcus Biosciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.